Texas Permanent School Fund’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-47,086
Closed -$889K 1101
2024
Q1
$889K Buy
47,086
+547
+1% +$9.46K 0.01% 1342
2023
Q4
$889K Buy
46,539
+1,001
+2% +$16K 0.01% 1332
2023
Q3
$817K Sell
45,538
-788
-2% -$15.8K 0.01% 1319
2023
Q2
$941K Sell
46,326
-428
-0.9% -$8.15K 0.01% 1275
2023
Q1
$853K Buy
46,754
+11,705
+33% +$224K 0.01% 1299
2022
Q4
$725K Sell
35,049
-2,321
-6% -$63.9K 0.01% 1237
2022
Q3
$978K Buy
37,370
+3,676
+11% +$97.2K 0.02% 1113
2022
Q2
$854K Buy
+33,694
New +$825K 0.01% 1192

Other funds holding RCUS

Texas Permanent School Fund's RCUS Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Arcus Biosciences (RCUS) in Q2 2024, closing a stake of 47,086 shares — an estimated $889K sold.

Texas Permanent School Fund first reported a position in RCUS in Q2 2022 and held it in 8 quarters. The position peaked at $978K in Q3 2022. 193 funds tracked by Wall St. Rank hold RCUS as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Arcus Biosciences position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 47,086 Arcus Biosciences shares in Q2 2024, an estimated $889K.
  • Texas Permanent School Fund first reported a position in Arcus Biosciences in Q2 2022 and held it in 8 quarters.
  • Texas Permanent School Fund's Arcus Biosciences position peaked at $978K in Q3 2022.
  • 193 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.